Stoke has a strategic collaboration with Biogen to develop and commercialize zorevunersen for Dravet syndrome. Under the collaboration, Stoke retains exclusive rights for zorevunersen in the United ...

Stoke has a strategic collaboration with Biogen to develop and commercialize zorevunersen for Dravet syndrome. Under the collaboration, Stoke retains exclusive rights for zorevunersen in the United ...

Venera - the duo of Korn guitarist James “Munky” Shaffer and composer/filmmaker Chris Hunt- have announced their second album, Exinfinite.

Under the collaboration, Stoke retains exclusive rights for zorevunersen in the United States, Canada, and Mexico; Biogen receives exclusive rest of world commercialization rights.

ClearBridge Investments, an investment management company, released its “ClearBridge Value Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.

Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS ...

Stoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS ...

– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – ...

Affiliate content: The best Shilajit gummies of 2025 offer convenient, tasty servings of purified, third‑party tested Himalayan resin rich in fulvic acid and trace minerals—often blended ...

BIIB begins phase III dosing of felzartamab primary membranous nephropathy study, targeting a tough-to-treat condition with no approved therapies.

The trial between Genentech Inc. and Biogen MA Inc. officially opened Monday in the U.S. District Court for the Northern District of California, centering on a $122 million royalties dispute related ...